Inhibition of experimental nephrocalcinosis with a prostaglandin synthetase inhibitor.
Nephrocalcinosis was induced in a group of experimental rats by means of intraperitoneal injections of 10% calcium gluconate. Two further groups of rats were treated with indomethacin and flurbiprofen (Froben) before receiving the i.p. calcium gluconate, to study the effects of prostaglandin inhibition on the process of renal parenchymal calcification. Tissue calcification was studied by means of contact microradiography and histology. Quantitative calcium analysis was by means of energy dispersive analysis of X-rays (EDAX). There was a marked inhibition of cortical nephrocalcinosis and a significantly reduced calcium concentration (P less than 0.005) in the animals treated with a prostaglandin inhibitor compared with the animals given i.p. calcium gluconate alone. This study suggests that prostaglandins are involved in the process of renal parenchymal calcification and may be aetiologically significant in the pathogenesis of stone formation.
D000818:Animals; D002118:Calcium / Q000032:analysis / Q000097:blood; D002125:Calcium Gluconate; D016861:Cyclooxygenase Inhibitors; D005260:Female; D005480:Flurbiprofen / Q000494:pharmacology*; D007213:Indomethacin / Q000494:pharmacology*; D007668:Kidney / Q000032:analysis / Q000473:pathology; D009397:Nephrocalcinosis / Q000139:chemically induced / Q000473:pathology / Q000517:prevention & control*; D011422:Propionates / Q000494:pharmacology*; D051381:Rats; D011919:Rats, Inbred Strains
D016861:Cyclooxygenase Inhibitors; D011422:Propionates; D005480:Flurbiprofen; D002125:Calcium Gluconate; D002118:Calcium; D007213:Indomethacin